Integrated Evaluation of Heart Rate Variability and Clinical Outcomes in Chronic Heart Failure: Insights into Cardiac Autonomic Dysfunction
Cardiac Autonomic Dysfunction in Chronic Heart Failure
DOI:
https://doi.org/10.69750/dmls.03.04.0201Keywords:
Heart rate variability, chronic heart failure, autonomic dysfunction, ventricular arrhythmias, cardiac outcomes, cardiovascular riskAbstract
Background: Chronic heart failure carries a significant cardiovascular morbidity and mortality burden globally. An imbalance in cardiac autonomic function with sympathetic predominance and parasympathetic recession is a prominent part of the disease process and its poor clinical outcome. HRV is a non-invasive indicator of ANS function in cardiovascular diseases.
Objective: To assess the relationship of heart rate variability (HRV) parameters with clinical outcomes in CHF patients and the prognostic value of cardiac autonomic dysfunction.
Methods: The cross-sectional study was an observational study conducted at Erie County Medical center, Buffalo from February 2023 to April 2025 under the reference number IRB/2023/CHF-117. A total of 300 patients with chronic heart failure were enrolled using consecutive non-probability sampling. Holter monitoring was done for 24 hours to calculate heart rate variability parameters such as SDNN, RMSSD, pNN50 and LF/HF ratio. New York Heart Association classification, echocardiographic findings, frequency of hospitalizations, arrhythmic complications and cardiovascular outcomes were assessed clinically. The SPSS 26.0 software was used for statistical analysis.
Results: Patients with severe autonomic dysfunction demonstrated significantly reduced SDNN, RMSSD, and pNN50 values together with elevated LF/HF ratio (p<0.001). Recurrent hospitalization, ventricular arrhythmias, worsening NYHA functional class, length of hospital stay and decreased LVEF were all significantly associated with severe HRV impairment. Multivariate logistic regression analysis revealed that reduced SDNN, elevated LF/HF ratio, diabetes mellitus, atrial fibrillation and reduced EF were independent factors in predicting adverse cardiovascular outcomes.
Conclusion: Reduced HRV is also a strong predictor of adverse clinical events in CHF. HRV assessment could be a valuable prognostic tool for the early stratification of cardiovascular risk and for individual patient management.
Downloads
References
Míková M, Pospíšil D, Řehoř J, Malik M. Heart rate variability analysis in congestive heart failure: the need for standardized assessment protocols. Rev Cardiovasc Med. 2025;26(5):36321. doi:10.31083/RCM36321.
Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Circulation. 1998;98(15):1510-1516. doi:10.1161/01.CIR.98.15.1510.
Yadav I, Waqas R, Mohammad A, Lashari UG, Sabra M, Dwayat A, et al. Heart rate variability as a predictor of mortality in heart failure: a systematic review and meta-analysis. Cureus. 2025;17(12):e99120. doi:10.7759/cureus.99120.
Basri AM, Turki AF. Evaluating heart rate variability as a biomarker for autonomic function in Parkinson’s disease rehabilitation: a clustering-based analysis of exercise-induced changes. Medicina (Kaunas). 2025;61(3):527. doi:10.3390/medicina61030527.
Olivieri F, Biscetti L, Pimpini L, Pelliccioni G, Sabbatinelli J, Giunta S. Heart rate variability and autonomic nervous system imbalance: potential biomarkers and detectable hallmarks of aging and inflammaging. Ageing Res Rev. 2024;101:102521. doi:10.1016/j.arr.2024.102521.
Wang BX, Brennand E, Le Page P, Mitchell ARJ. Heart rate variability in cardiovascular disease diagnosis, prognosis and management. Front Cardiovasc Med. 2026;12:1680783. doi:10.3389/fcvm.2025.1680783.
Yang S, Wu H, Liao X, Lin Y, Liou JJ. Advancing entropy analysis for heart rate variability: clinical insights for aging and diabetes. Front Physiol. 2026;17:1795118. doi:10.3389/fphys.2026.1795118.
Besson C, Baggish AL, Monteventi P, Schmitt L, Stucky F, Gremeaux V. Assessing the clinical reliability of short-term heart rate variability: insights from controlled dual-environment and dual-position measurements. Sci Rep. 2025;15(1):5611. doi:10.1038/s41598-025-89892-3.
Ceren İ. Heart rate variability in myocardial infarction: a marker of autonomic dysfunction and clinical prognosis. In: Ciobanu A, editor. Heart Rate Variability - Current Practices and Clinical Applications. London: IntechOpen; 2025. doi:10.5772/intechopen.1011156.
Widatalla N, Younis SA, Khandoker A. Heart rate transition patterns reveal autonomic dysfunction in heart failure with renal function decline: a symbolic and Markov model approach. BioData Min. 2025;18:45. doi:10.1186/s13040-025-00460-x.
Günther A, Witte H, Hoyer D. Autonomic dysfunction and risk stratification assessed from heart rate pattern. Open Neurol J. 2010;4:39-49. doi:10.2174/1874205X01004010039.
Velmeden D, Söhne J, Schuch A, Zeid S, Schulz A, Troebs SO, et al. Role of heart rate recovery in chronic heart failure: results from the MyoVasc study. J Am Heart Assoc. 2025;14(10):e039792. doi:10.1161/JAHA.124.039792.
Sandu OE, Bogdan C, Apostol A, Simu MA, Moga VD, Pecingina RM, et al. Heart rate variability dynamics as predictors of functional recovery and mortality after acute ischemic stroke. Biomedicines. 2025;13(9):2217. doi:10.3390/biomedicines13092217.
Yadav I, Waqas R, Mohammad A, Lashari UG, Sabra M, Dwayat A, Rajput J. Heart rate variability as a predictor of mortality in heart failure: a systematic review and meta-analysis. Cureus. 2025;17(12):e99120. doi:10.7759/cureus.99120.
Refisch A, Schumann A, Gupta Y, et al. Characterization of cardiac autonomic dysfunction in acute schizophrenia: a cluster analysis of heart rate variability parameters. Schizophr (Heidelb). 2025;11:40. doi:10.1038/s41537-025-00589-y.
Kumar R. Cardiac autonomic regulation: emerging biomarkers and clinical implications. In: Ciobanu A, editor. Heart Rate Variability - Current Practices and Clinical Applications. London: IntechOpen; 2025. doi:10.5772/intechopen.1012396.
Zhang F, Zhang X, Jian J, Zeng X, Zheng C, Zhang Y, et al. Heart failure: mechanistic insights and precision therapeutic strategies. Front Cardiovasc Med. 2025;12:1696793. doi:10.3389/fcvm.2025.1696793.
Hayashi R, Hasegawa M, Hatanaka A, Mandour AS, Hirose M, Shimada K, et al. Evaluation of changes in heart rate variability associated with puppy growth using phase-rectified signal averaging (PRSA) and non-gaussianity index. Animals (Basel). 2025;15(23):3449. doi:10.3390/ani15233449.
Burlacu A, Brinza C, Geman O, Karppa M, Hemanth DJ. Heart rate variability as a dual-use digital biomarker: integrating clinical, AI, and operational perspectives on human performance and resilience. BMC Cardiovasc Disord. 2026;26(1):87. doi:10.1186/s12872-026-05543-z.
Bustos N, Giubergia F, Mora C, Lara C, Urzúa Á, Cattaneo M, et al. Heart rate variability in the clinical assessment of patients with chronic liver disease. World J Hepatol. 2025;17(7):106291. doi:10.4254/wjh.v17.i7.106291.
Downloads
Published
Issue
Section
License
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you must obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.














